You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (AML) (1)

Lymphoma (1)

Myelodysplastic Syndromes(MDS) (1)

Solid Tumor (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

AbbVie (1)

I-Mab Biopharma Co. Ltd. (1)

Collaborator

I-Mab Biopharma Co. Ltd. (1)

Intervention

tj011133 (2)

pembrolizumab (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

tj011133

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

Active, not recruiting

Solid Tumor
Lymphoma

TJ011133
+2 more

Birmingham, Alabama
+20 more

Aug 22, 2022

Acute Myeloid Leukemia (AML), MDS(MDS) Trial in China (TJ011133)

Recruiting

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes(MDS)

TJ011133

Beijing, Beijing, China
+25 more

Jul 29, 2021